<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2018-01-31" version="219">
<accession>Q92793</accession>
<accession>D3DUC9</accession>
<accession>O00147</accession>
<accession>Q16376</accession>
<accession>Q4LE28</accession>
<name>CBP_HUMAN</name>
<protein>
<recommendedName>
<fullName>CREB-binding protein</fullName>
<ecNumber evidence="61">2.3.1.48</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">CREBBP</name>
<name type="synonym">CBP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="8732" last="8737">
<title>MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).</title>
<authorList>
<person name="Sobulo O.M."/>
<person name="Borrow J."/>
<person name="Tomek R."/>
<person name="Reshimi S."/>
<person name="Harden A."/>
<person name="Schlegelberger B."/>
<person name="Housman D."/>
<person name="Doggett N.A."/>
<person name="Rowley J.D."/>
<person name="Zeleznik-Le N.J."/>
</authorList>
<dbReference type="PubMed" id="9238046"/>
<dbReference type="DOI" id="10.1073/pnas.94.16.8732"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Genomics" volume="42" first="96" last="114">
<title>Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3.</title>
<authorList>
<person name="Giles R.H."/>
<person name="Petrij F."/>
<person name="Dauwerse H.G."/>
<person name="den Hollander A.I."/>
<person name="Lushnikova T."/>
<person name="van Ommen G.J.B."/>
<person name="Goodman R.H."/>
<person name="Deaven L.L."/>
<person name="Doggett N.A."/>
<person name="Peters D.J.M."/>
<person name="Breuning M.H."/>
</authorList>
<dbReference type="PubMed" id="9177780"/>
<dbReference type="DOI" id="10.1006/geno.1997.4699"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="1999-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Petrij F."/>
<person name="den Hollander A.I."/>
<person name="Chrivia J.C."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 1724-1725; 1789 AND 1812</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<title>Preparation of a set of expression-ready clones of mammalian long cDNAs encoding large proteins by the ORF trap cloning method.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Saito K."/>
<person name="Yamakawa H."/>
<person name="Kikuno R.F."/>
<person name="Nakayama M."/>
<person name="Ohara R."/>
<person name="Okazaki N."/>
<person name="Koga H."/>
<person name="Nagase T."/>
<person name="Ohara O."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1996" name="Nat. Genet." volume="14" first="33" last="41">
<title>The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.</title>
<authorList>
<person name="Borrow J."/>
<person name="Stanton V.P. Jr."/>
<person name="Andresen J.M."/>
<person name="Becher R."/>
<person name="Behm F.G."/>
<person name="Chaganti R.S.K."/>
<person name="Civin C.I."/>
<person name="Disteche C."/>
<person name="Dube I."/>
<person name="Frischauf A.M."/>
<person name="Horsman D."/>
<person name="Mitelman F."/>
<person name="Volinia S."/>
<person name="Watmore A.E."/>
<person name="Housman D.E."/>
</authorList>
<dbReference type="PubMed" id="8782817"/>
<dbReference type="DOI" id="10.1038/ng0996-33"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-405</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH KAT6A</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="395" last="404">
<title>Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).</title>
<authorList>
<person name="Panagopoulos I."/>
<person name="Fioretos T."/>
<person name="Isaksson M."/>
<person name="Samuelsson U."/>
<person name="Billstroem R."/>
<person name="Stroembeck B."/>
<person name="Mitelman F."/>
<person name="Johansson B."/>
</authorList>
<dbReference type="PubMed" id="11157802"/>
<dbReference type="DOI" id="10.1093/hmg/10.4.395"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-83</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH KAT6B</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="Nature" volume="382" first="319" last="324">
<title>A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.</title>
<authorList>
<person name="Yang X.-J."/>
<person name="Ogryzko V.V."/>
<person name="Nishikawa J."/>
<person name="Howard B.H."/>
<person name="Nakatani Y."/>
</authorList>
<dbReference type="PubMed" id="8684459"/>
<dbReference type="DOI" id="10.1038/382319a0"/>
</citation>
<scope>INTERACTION WITH PCAF</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="12969" last="12973">
<title>An essential role for p300/CBP in the cellular response to hypoxia.</title>
<authorList>
<person name="Arany Z."/>
<person name="Huang L.E."/>
<person name="Eckner R."/>
<person name="Bhattacharya S."/>
<person name="Jiang C."/>
<person name="Goldberg M.A."/>
<person name="Bunn H.F."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="8917528"/>
<dbReference type="DOI" id="10.1073/pnas.93.23.12969"/>
</citation>
<scope>INTERACTION WITH HIF1A AND EP300</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="Cell" volume="90" first="1107" last="1112">
<title>RNA helicase A mediates association of CBP with RNA polymerase II.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Uchida C."/>
<person name="Anderson S.F."/>
<person name="Lee C.-G."/>
<person name="Hurwitz J."/>
<person name="Parvin J.D."/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="9323138"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80376-1"/>
</citation>
<scope>INTERACTION WITH DHX9</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="2392" last="2405">
<title>Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300.</title>
<authorList>
<person name="Bex F."/>
<person name="Yin M.-J."/>
<person name="Burny A."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="9528808"/>
<dbReference type="DOI" id="10.1128/MCB.18.4.2392"/>
</citation>
<scope>INTERACTION WITH HTLV-1 TAX</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="9855" last="9860">
<title>Acetylation and modulation of erythroid Krueppel-like factor (EKLF) activity by interaction with histone acetyltransferases.</title>
<authorList>
<person name="Zhang W."/>
<person name="Bieker J.J."/>
</authorList>
<dbReference type="PubMed" id="9707565"/>
<dbReference type="DOI" id="10.1073/pnas.95.17.9855"/>
</citation>
<scope>INTERACTION WITH KLF1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="16370" last="16376">
<title>Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein.</title>
<authorList>
<person name="Johnston H."/>
<person name="Kneer J."/>
<person name="Chackalaparampil I."/>
<person name="Yaciuk P."/>
<person name="Chrivia J."/>
</authorList>
<dbReference type="PubMed" id="10347196"/>
<dbReference type="DOI" id="10.1074/jbc.274.23.16370"/>
</citation>
<scope>INTERACTION WITH SRCAP</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="2627" last="2632">
<title>Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.</title>
<authorList>
<person name="Doucas V."/>
<person name="Tini M."/>
<person name="Egan D.A."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="10077561"/>
<dbReference type="DOI" id="10.1073/pnas.96.6.2627"/>
</citation>
<scope>INTERACTION WITH PML</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Cell" volume="98" first="675" last="686">
<title>Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.</title>
<authorList>
<person name="Chen H."/>
<person name="Lin R.J."/>
<person name="Xie W."/>
<person name="Wilpitz D."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="10490106"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80054-9"/>
</citation>
<scope>ACETYLATION OF NCOA3</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="8825" last="8834">
<title>The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors.</title>
<authorList>
<person name="Yahata T."/>
<person name="de Caestecker M.P."/>
<person name="Lechleider R.J."/>
<person name="Andriole S."/>
<person name="Roberts A.B."/>
<person name="Isselbacher K.J."/>
<person name="Shioda T."/>
</authorList>
<dbReference type="PubMed" id="10722728"/>
<dbReference type="DOI" id="10.1074/jbc.275.12.8825"/>
</citation>
<scope>INTERACTION WITH CITED1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="5048" last="5063">
<title>A new family of nuclear receptor coregulators that integrates nuclear receptor signaling through CBP.</title>
<authorList>
<person name="Mahajan M.A."/>
<person name="Samuels H.H."/>
</authorList>
<dbReference type="PubMed" id="10866662"/>
<dbReference type="DOI" id="10.1128/MCB.20.14.5048-5063.2000"/>
</citation>
<scope>INTERACTION WITH NCOA6</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="10715" last="10721">
<title>Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation.</title>
<authorList>
<person name="Hung H.-L."/>
<person name="Kim A.Y."/>
<person name="Hong W."/>
<person name="Rakowski C."/>
<person name="Blobel G.A."/>
</authorList>
<dbReference type="PubMed" id="11154691"/>
<dbReference type="DOI" id="10.1074/jbc.M007846200"/>
</citation>
<scope>INTERACTION WITH MAFG</scope>
<scope>FUNCTION IN ACETYLATION OF MAFG</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="39569" last="39576">
<title>Requirement of two NFATc4 transactivation domains for CBP potentiation.</title>
<authorList>
<person name="Yang T.T.C."/>
<person name="Davis R.J."/>
<person name="Chow C.-W."/>
</authorList>
<dbReference type="PubMed" id="11514544"/>
<dbReference type="DOI" id="10.1074/jbc.M102961200"/>
</citation>
<scope>INTERACTION WITH NFATC4</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="44936" last="44943">
<title>Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles.</title>
<authorList>
<person name="Chakraborty S."/>
<person name="Senyuk V."/>
<person name="Sitailo S."/>
<person name="Chi Y."/>
<person name="Nucifora G."/>
</authorList>
<dbReference type="PubMed" id="11568182"/>
<dbReference type="DOI" id="10.1074/jbc.M106733200"/>
</citation>
<scope>INTERACTION WITH MECOM</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="5520" last="5530">
<title>The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation.</title>
<authorList>
<person name="Scoggin K.E.S."/>
<person name="Ulloa A."/>
<person name="Nyborg J.K."/>
</authorList>
<dbReference type="PubMed" id="11463834"/>
<dbReference type="DOI" id="10.1128/MCB.21.16.5520-5530.2001"/>
</citation>
<scope>INTERACTION WITH HTLV-1 TAX</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="J. Virol." volume="75" first="9885" last="9895">
<title>Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.</title>
<authorList>
<person name="Zhang W."/>
<person name="Nisbet J.W."/>
<person name="Albrecht B."/>
<person name="Ding W."/>
<person name="Kashanchi F."/>
<person name="Bartoe J.T."/>
<person name="Lairmore M.D."/>
</authorList>
<dbReference type="PubMed" id="11559821"/>
<dbReference type="DOI" id="10.1128/JVI.75.20.9885-9895.2001"/>
</citation>
<scope>INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P30II</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="33881" last="33892">
<title>A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression.</title>
<authorList>
<person name="Gizard F."/>
<person name="Lavallee B."/>
<person name="DeWitte F."/>
<person name="Hum D.W."/>
</authorList>
<dbReference type="PubMed" id="11349124"/>
<dbReference type="DOI" id="10.1074/jbc.M100113200"/>
</citation>
<scope>INTERACTION WITH TRERF1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="38272" last="38279">
<title>Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.</title>
<authorList>
<person name="Vadlamudi R.K."/>
<person name="Wang R.-A."/>
<person name="Mazumdar A."/>
<person name="Kim Y.-S."/>
<person name="Shin J."/>
<person name="Sahin A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="11481323"/>
<dbReference type="DOI" id="10.1074/jbc.M103783200"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="800" last="811">
<title>HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators.</title>
<authorList>
<person name="Lin R."/>
<person name="Genin P."/>
<person name="Mamane Y."/>
<person name="Sgarbanti M."/>
<person name="Battistini A."/>
<person name="Harrington W.J. Jr."/>
<person name="Barber G.N."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="11314014"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204163"/>
</citation>
<scope>INTERACTION WITH HHV-8 PROTEIN VIRF1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="Cell Growth Differ." volume="13" first="69" last="75">
<title>Interaction between the hematopoietic Ets transcription factor Spi-B and the coactivator CREB-binding protein associated with negative cross-talk with c-Myb.</title>
<authorList>
<person name="Yamamoto H."/>
<person name="Kihara-Negishi F."/>
<person name="Yamada T."/>
<person name="Suzuki M."/>
<person name="Nakano T."/>
<person name="Oikawa T."/>
</authorList>
<dbReference type="PubMed" id="11864910"/>
</citation>
<scope>INTERACTION WITH SPIB</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="8559" last="8565">
<title>Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2.</title>
<authorList>
<person name="Braganca J."/>
<person name="Swingler T."/>
<person name="Marques F.I.R."/>
<person name="Jones T."/>
<person name="Eloranta J.J."/>
<person name="Hurst H.C."/>
<person name="Shioda T."/>
<person name="Bhattacharya S."/>
</authorList>
<dbReference type="PubMed" id="11744733"/>
<dbReference type="DOI" id="10.1074/jbc.M110850200"/>
</citation>
<scope>INTERACTION WITH CITED4</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3549" last="3561">
<title>Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase.</title>
<authorList>
<person name="Wu R.-C."/>
<person name="Qin J."/>
<person name="Hashimoto Y."/>
<person name="Wong J."/>
<person name="Xu J."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.-J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="11971985"/>
<dbReference type="DOI" id="10.1128/MCB.22.10.3549-3561.2002"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH NCOA2; NCOA3; IKKA; IKKB AND IKBKG</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="25401" last="25407">
<title>Interferon regulatory factor-2 regulates cell growth through its acetylation.</title>
<authorList>
<person name="Masumi A."/>
<person name="Yamakawa Y."/>
<person name="Fukazawa H."/>
<person name="Ozato K."/>
<person name="Komuro K."/>
</authorList>
<dbReference type="PubMed" id="12738767"/>
<dbReference type="DOI" id="10.1074/jbc.M213037200"/>
</citation>
<scope>INTERACTION WITH IRF2</scope>
<scope>FUNCTION IN ACETYLATION OF IRF2</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="26102" last="26110">
<title>Identification and characterization of BCL-3-binding protein: implications for transcription and DNA repair or recombination.</title>
<authorList>
<person name="Watanabe N."/>
<person name="Wachi S."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="12730195"/>
<dbReference type="DOI" id="10.1074/jbc.M303518200"/>
</citation>
<scope>INTERACTION WITH N4BP2</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2003" name="J. Bone Miner. Res." volume="18" first="1419" last="1429">
<title>P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.</title>
<authorList>
<person name="Iioka T."/>
<person name="Furukawa K."/>
<person name="Yamaguchi A."/>
<person name="Shindo H."/>
<person name="Yamashita S."/>
<person name="Tsukazaki T."/>
</authorList>
<dbReference type="PubMed" id="12929931"/>
<dbReference type="DOI" id="10.1359/jbmr.2003.18.8.1419"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7091" last="7097">
<title>Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.</title>
<authorList>
<person name="Curtis A.M."/>
<person name="Seo S.B."/>
<person name="Westgate E.J."/>
<person name="Rudic R.D."/>
<person name="Smyth E.M."/>
<person name="Chakravarti D."/>
<person name="FitzGerald G.A."/>
<person name="McNamara P."/>
</authorList>
<dbReference type="PubMed" id="14645221"/>
<dbReference type="DOI" id="10.1074/jbc.M311973200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NPAS2 AND CLOCK</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="25241" last="25250">
<title>Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86.</title>
<authorList>
<person name="Wang H."/>
<person name="Fang R."/>
<person name="Cho J.-Y."/>
<person name="Libermann T.A."/>
<person name="Oettgen P."/>
</authorList>
<dbReference type="PubMed" id="15075319"/>
<dbReference type="DOI" id="10.1074/jbc.M401356200"/>
</citation>
<scope>INTERACTION WITH ELF3</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="28873" last="28879">
<title>FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1).</title>
<authorList>
<person name="van der Horst A."/>
<person name="Tertoolen L.G.J."/>
<person name="de Vries-Smits L.M.M."/>
<person name="Frye R.A."/>
<person name="Medema R.H."/>
<person name="Burgering B.M.T."/>
</authorList>
<dbReference type="PubMed" id="15126506"/>
<dbReference type="DOI" id="10.1074/jbc.M401138200"/>
</citation>
<scope>INTERACTION WITH MLLT7</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2004" name="Neurosci. Lett." volume="370" first="191" last="195">
<title>The calcium-responsive transactivator recruits CREB binding protein to nuclear bodies.</title>
<authorList>
<person name="Pradhan A."/>
<person name="Liu Y."/>
</authorList>
<dbReference type="PubMed" id="15488321"/>
<dbReference type="DOI" id="10.1016/j.neulet.2004.08.062"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="10042" last="10047">
<title>Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.</title>
<authorList>
<person name="Daitoku H."/>
<person name="Hatta M."/>
<person name="Matsuzaki H."/>
<person name="Aratani S."/>
<person name="Ohshima T."/>
<person name="Miyagishi M."/>
<person name="Nakajima T."/>
<person name="Fukamizu A."/>
</authorList>
<dbReference type="PubMed" id="15220471"/>
<dbReference type="DOI" id="10.1073/pnas.0400593101"/>
</citation>
<scope>INTERACTION WITH FOXO1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2004" name="Science" volume="303" first="197" last="202">
<title>Dendrite development regulated by CREST, a calcium-regulated transcriptional activator.</title>
<authorList>
<person name="Aizawa H."/>
<person name="Hu S.-C."/>
<person name="Bobb K."/>
<person name="Balakrishnan K."/>
<person name="Ince G."/>
<person name="Gurevich I."/>
<person name="Cowan M."/>
<person name="Ghosh A."/>
</authorList>
<dbReference type="PubMed" id="14716005"/>
<dbReference type="DOI" id="10.1126/science.1089845"/>
</citation>
<scope>INTERACTION WITH SS18L1/CREST</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2007" name="Mol. Cell" volume="26" first="75" last="87">
<title>Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB.</title>
<authorList>
<person name="Huang W.C."/>
<person name="Ju T.K."/>
<person name="Hung M.C."/>
<person name="Chen C.C."/>
</authorList>
<dbReference type="PubMed" id="17434128"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.02.019"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1382 AND SER-1386 BY CHUK/IKKA</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1030</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="1478" last="1484">
<title>Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1.</title>
<authorList>
<person name="Sarkar D."/>
<person name="Park E.S."/>
<person name="Emdad L."/>
<person name="Lee S.-G."/>
<person name="Su Z.-Z."/>
<person name="Fisher P.B."/>
</authorList>
<dbReference type="PubMed" id="18316612"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-6164"/>
</citation>
<scope>INTERACTION WITH MTDH</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121; SER-2063; SER-2076 AND SER-2079</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2063</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1014; LYS-1216; LYS-1583; LYS-1591; LYS-1592; LYS-1595; LYS-1597; LYS-1741 AND LYS-1744</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1076; SER-1763 AND SER-2063</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="49">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-220</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="8433" last="8448">
<title>CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis.</title>
<authorList>
<person name="Cazzalini O."/>
<person name="Sommatis S."/>
<person name="Tillhon M."/>
<person name="Dutto I."/>
<person name="Bachi A."/>
<person name="Rapp A."/>
<person name="Nardo T."/>
<person name="Scovassi A.I."/>
<person name="Necchi D."/>
<person name="Cardoso M.C."/>
<person name="Stivala L.A."/>
<person name="Prosperi E."/>
</authorList>
<dbReference type="PubMed" id="24939902"/>
<dbReference type="DOI" id="10.1093/nar/gku533"/>
</citation>
<scope>FUNCTION AS ACETYLTRANSFERASE OF PCNA</scope>
<scope>INTERACTION WITH PCNA</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="5271" last="5276">
<title>Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response.</title>
<authorList>
<person name="Dames S.A."/>
<person name="Martinez-Yamout M."/>
<person name="De Guzman R.N."/>
<person name="Dyson H.J."/>
<person name="Wright P.E."/>
</authorList>
<dbReference type="PubMed" id="11959977"/>
<dbReference type="DOI" id="10.1073/pnas.082121399"/>
</citation>
<scope>STRUCTURE BY NMR OF 345-439 IN COMPLEX WITH 776-826 OF HIF1A</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="7184" last="7196">
<title>Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.</title>
<authorList>
<person name="Kitabayashi I."/>
<person name="Aikawa Y."/>
<person name="Nguyen L.A."/>
<person name="Yokoyama A."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="11742995"/>
<dbReference type="DOI" id="10.1093/emboj/20.24.7184"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH KAT6A</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2004" name="Biochemistry" volume="43" first="904" last="908">
<title>NMR mapping of the HIV-1 Tat interaction surface of the KIX domain of the human coactivator CBP.</title>
<authorList>
<person name="Vendel A.C."/>
<person name="Lumb K.J."/>
</authorList>
<dbReference type="PubMed" id="14744133"/>
<dbReference type="DOI" id="10.1021/bi035612l"/>
</citation>
<scope>STRUCTURE BY NMR OF 589-679 IN COMPLEX WITH HIV-1 TAT</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2012" name="Cell" volume="149" first="214" last="231">
<title>Histone recognition and large-scale structural analysis of the human bromodomain family.</title>
<authorList>
<person name="Filippakopoulos P."/>
<person name="Picaud S."/>
<person name="Mangos M."/>
<person name="Keates T."/>
<person name="Lambert J.P."/>
<person name="Barsyte-Lovejoy D."/>
<person name="Felletar I."/>
<person name="Volkmer R."/>
<person name="Muller S."/>
<person name="Pawson T."/>
<person name="Gingras A.C."/>
<person name="Arrowsmith C.H."/>
<person name="Knapp S."/>
</authorList>
<dbReference type="PubMed" id="22464331"/>
<dbReference type="DOI" id="10.1016/j.cell.2012.02.013"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1081-1197</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="E1072" last="E1081">
<title>Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.</title>
<authorList>
<person name="Das C."/>
<person name="Roy S."/>
<person name="Namjoshi S."/>
<person name="Malarkey C.S."/>
<person name="Jones D.N."/>
<person name="Kutateladze T.G."/>
<person name="Churchill M.E."/>
<person name="Tyler J.K."/>
</authorList>
<dbReference type="PubMed" id="24616510"/>
<dbReference type="DOI" id="10.1073/pnas.1319122111"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 1082-1197</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ASF1A; ASF1B; ACETYLATED HISTONES AND TP53</scope>
<scope>MUTAGENESIS OF ASP-1116; PHE-1126; ASN-1162; TRP-1165; SER-1179; LYS-1180 AND GLU-1183</scope>
<scope>CHARACTERIZATION OF VARIANT RSTS1 CYS-1175</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOACETYLATION</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2014" name="Structure" volume="22" first="353" last="360">
<title>Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP.</title>
<authorList>
<person name="Plotnikov A.N."/>
<person name="Yang S."/>
<person name="Zhou T.J."/>
<person name="Rusinova E."/>
<person name="Frasca A."/>
<person name="Zhou M.M."/>
</authorList>
<dbReference type="PubMed" id="24361270"/>
<dbReference type="DOI" id="10.1016/j.str.2013.10.021"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.83 ANGSTROMS) OF 1080-1316 IN COMPLEX WITH ZINC</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="1071" last="1076">
<title>Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.</title>
<authorList>
<person name="Murata T."/>
<person name="Kurokawa R."/>
<person name="Krones A."/>
<person name="Tatsumi K."/>
<person name="Ishii M."/>
<person name="Taki T."/>
<person name="Masuno M."/>
<person name="Ohashi H."/>
<person name="Yanagisawa M."/>
<person name="Rosenfeld M.G."/>
<person name="Glass C.K."/>
<person name="Hayashi Y."/>
</authorList>
<dbReference type="PubMed" id="11331617"/>
<dbReference type="DOI" id="10.1093/hmg/10.10.1071"/>
</citation>
<scope>VARIANT RSTS1 PRO-1378</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2002" name="J. Med. Genet." volume="39" first="496" last="501">
<title>Molecular studies in 10 cases of Rubinstein-Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP.</title>
<authorList>
<person name="Bartsch O."/>
<person name="Locher K."/>
<person name="Meinecke P."/>
<person name="Kress W."/>
<person name="Seemanova E."/>
<person name="Wagner A."/>
<person name="Ostermann K."/>
<person name="Roedel G."/>
</authorList>
<dbReference type="PubMed" id="12114483"/>
<dbReference type="DOI" id="10.1136/jmg.39.7.496"/>
</citation>
<scope>VARIANT RSTS1 CYS-1175</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="441" last="450">
<title>Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.</title>
<authorList>
<person name="Kalkhoven E."/>
<person name="Roelfsema J.H."/>
<person name="Teunissen H."/>
<person name="den Boer A."/>
<person name="Ariyuerek Y."/>
<person name="Zantema A."/>
<person name="Breuning M.H."/>
<person name="Hennekam R.C.M."/>
<person name="Peters D.J.M."/>
</authorList>
<dbReference type="PubMed" id="12566391"/>
<dbReference type="DOI" id="10.1093/hmg/ddg039"/>
</citation>
<scope>VARIANTS RSTS1 LYS-1278 AND HIS-1664</scope>
<scope>CHARACTERIZATION OF VARIANTS RSTS1 LYS-1278 AND HIS-1664</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2005" name="Am. J. Hum. Genet." volume="76" first="572" last="580">
<title>Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.</title>
<authorList>
<person name="Roelfsema J.H."/>
<person name="White S.J."/>
<person name="Ariyuerek Y."/>
<person name="Bartholdi D."/>
<person name="Niedrist D."/>
<person name="Papadia F."/>
<person name="Bacino C.A."/>
<person name="den Dunnen J.T."/>
<person name="van Ommen G.-J.B."/>
<person name="Breuning M.H."/>
<person name="Hennekam R.C."/>
<person name="Peters D.J.M."/>
</authorList>
<dbReference type="PubMed" id="15706485"/>
<dbReference type="DOI" id="10.1086/429130"/>
</citation>
<scope>VARIANTS RSTS1 LYS-1278; ILE-1447; HIS-1450; ARG-1470 AND HIS-1664</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2010" name="Am. J. Med. Genet. A" volume="152A" first="2254" last="2261">
<title>Inheritance and variable expression in Rubinstein-Taybi syndrome.</title>
<authorList>
<person name="Bartsch O."/>
<person name="Kress W."/>
<person name="Kempf O."/>
<person name="Lechno S."/>
<person name="Haaf T."/>
<person name="Zechner U."/>
</authorList>
<dbReference type="PubMed" id="20684013"/>
<dbReference type="DOI" id="10.1002/ajmg.a.33598"/>
</citation>
<scope>VARIANT RSTS1 ALA-910</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2015" name="Clin. Genet." volume="88" first="431" last="440">
<title>Insights into genotype-phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein-Taybi syndrome patients.</title>
<authorList>
<person name="Spena S."/>
<person name="Milani D."/>
<person name="Rusconi D."/>
<person name="Negri G."/>
<person name="Colapietro P."/>
<person name="Elcioglu N."/>
<person name="Bedeschi F."/>
<person name="Pilotta A."/>
<person name="Spaccini L."/>
<person name="Ficcadenti A."/>
<person name="Magnani C."/>
<person name="Scarano G."/>
<person name="Selicorni A."/>
<person name="Larizza L."/>
<person name="Gervasini C."/>
</authorList>
<dbReference type="PubMed" id="25388907"/>
<dbReference type="DOI" id="10.1111/cge.12537"/>
</citation>
<scope>VARIANTS HIS-503; THR-532 AND ASN-546</scope>
<scope>VARIANTS RSTS1 PHE-650; THR-789; CYS-1175; ALA-1278; PRO-1378; TYR-1406; PRO-1415; THR-1475; PHE-1503; PRO-1507 AND ASN-1543</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2016" name="Am. J. Med. Genet. A" volume="170" first="2681" last="2693">
<title>CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype.</title>
<authorList>
<consortium name="DDD Study"/>
<person name="Menke L.A."/>
<person name="van Belzen M.J."/>
<person name="Alders M."/>
<person name="Cristofoli F."/>
<person name="Ehmke N."/>
<person name="Fergelot P."/>
<person name="Foster A."/>
<person name="Gerkes E.H."/>
<person name="Hoffer M.J."/>
<person name="Horn D."/>
<person name="Kant S.G."/>
<person name="Lacombe D."/>
<person name="Leon E."/>
<person name="Maas S.M."/>
<person name="Melis D."/>
<person name="Muto V."/>
<person name="Park S.M."/>
<person name="Peeters H."/>
<person name="Peters D.J."/>
<person name="Pfundt R."/>
<person name="van Ravenswaaij-Arts C.M."/>
<person name="Tartaglia M."/>
<person name="Hennekam R.C."/>
</authorList>
<dbReference type="PubMed" id="27311832"/>
<dbReference type="DOI" id="10.1002/ajmg.a.37800"/>
</citation>
<scope>INVOLVEMENT IN RUBINSTEIN-TAYBI-LIKE SYNDROME</scope>
<scope>VARIANTS ARG-1710; ARG-1747; PRO-1786; PHE-1819; TRP-1826; TYR-1838; GLN-1867; TRP-1867; TRP-1868 AND VAL-1872</scope>
</reference>
<comment type="function">
<text evidence="32 48 49 50 62 69">Acetylates histones, giving a specific tag for transcriptional activation. Also acetylates non-histone proteins, like NCOA3 and FOXO1. Binds specifically to phosphorylated CREB and enhances its transcriptional activity toward cAMP-responsive genes. Acts as a coactivator of ALX1. Acts as a circadian transcriptional coactivator which enhances the activity of the circadian transcriptional activators: NPAS2-ARNTL/BMAL1 and CLOCK-ARNTL/BMAL1 heterodimers. Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed:24939902).</text>
</comment>
<comment type="catalytic activity">
<text evidence="61">Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine.</text>
</comment>
<comment type="subunit">
<text evidence="20 28 29 30 31 32 33 35 36 37 38 39 40 41 42 43 44 47 48 50 51 52 53 54 55 58 61 62 65 66 67 68 69">Found in a complex containing NCOA2; NCOA3; IKKA; IKKB and IKBKG. Probably part of a complex with HIF1A and EP300. Interacts with GATA1; the interaction results in acetylation and enhancement of transcriptional activity of GATA1. Interacts with MAF AND ZCCHC12. Interacts with DAXX; the interaction is dependent on CBP sumoylation and results in suppression of the transcriptional activity via recruitment of HDAC2 to DAXX (By similarity). Interacts with phosphorylated CREB1. Interacts with CITED4 (C-terminal region). Interacts (via the TAZ-type 1 domain) with HIF1A. Interacts with SRCAP, CARM1, ELF3, MLLT7/FOXO4, N4BP2, NCOA1, NCOA3, NCOA6, PCAF, DDX5, DDX17, PELP1, PML, SMAD1, SMAD2, SMAD3, SPIB and TRERF1. Interacts with HTLV-1 Tax and p30II. Interacts with HIV-1 Tat. Interacts with KLF1; the interaction results in acetylation of KLF1 and enhancement of its transcriptional activity. Interacts with MTDH. Interacts with NFATC4. Interacts with MAFG; the interaction acetylates MAFG in the basic region and stimulates NFE2 transcriptional activity through increasing its DNA-binding activity. Interacts with IRF2; the interaction acetylates IRF2 and regulates its activity on the H4 promoter. Interacts (via N-terminus) with SS18L1/CREST (via C-terminus). Interacts with MECOM. Interacts with CITED1 (via C-terminus). Interacts with FOXO1; the interaction acetylates FOXO1 and inhibits its transcriptional activity. Interacts with human herpes virus 8/HHV-8 protein vIRF-1; this interaction inhibits CREBBP binding to IRF3. Interacts with NPAS2, CLOCK and ARNTL/BMAL1. Interacts with ASF1A and ASF1B; this promotes histone acetylation. Interacts with acetylated TP53/p53 and with the acetylated histones H3 and H4. Interacts (via transactivation domain and C-terminus) with PCNA; the interaction occurs on chromatin in UV-irradiated damaged cells (PubMed:24939902). Interacts with DHX9 (via N-terminus); this interaction mediates association with RNA polymerase II holoenzyme and stimulates CREB-dependent transcriptional activation (PubMed:9323138).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-617698">
<id>P03070</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-2603114">
<id>P03255</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-6947456">
<id>P03259</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-7225021">
<id>P03259-2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-1050386">
<id>P61201</id>
<label>COPS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-711855">
<id>P16220</id>
<label>CREB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-1108782">
<id>Q12778</id>
<label>FOXO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-1644164">
<id>O43524</id>
<label>FOXO3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-302023">
<id>P62805</id>
<label>HIST2H4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-958408">
<id>P48551</id>
<label>IFNAR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-2650369">
<id>Q14653</id>
<label>IRF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-3931258">
<id>Q13568</id>
<label>IRF5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-477430">
<id>Q92831</id>
<label>KAT2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-8284732">
<id>Q13351</id>
<label>KLF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-1046588">
<id>Q86UE4</id>
<label>MTDH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-356392">
<id>P55209</id>
<label>NAP1L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-78670">
<id>Q14686</id>
<label>NCOA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-1045459">
<id>O95863</id>
<label>SNAI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-948328">
<id>P36956-1</id>
<label>SREBF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-948338">
<id>P36956-3</id>
<label>SREBF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-465059">
<id>Q12772</id>
<label>SREBF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-6164389">
<id>P04608</id>
<label>tat</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-3922312">
<id>Q9UL17</id>
<label>TBX21</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81215"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Recruited to nuclear bodies by SS18L1/CREST. In the presence of ALX1 relocalizes from the cytoplasm to the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q92793-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q92793-2</id>
<name>2</name>
<sequence type="described" ref="VSP_045700"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="domain">
<text>The KIX domain mediates binding to HIV-1 Tat.</text>
</comment>
<comment type="PTM">
<text evidence="20">Methylation of the KIX domain by CARM1 blocks association with CREB. This results in the blockade of CREB signaling, and in activation of apoptotic response (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="57">Phosphorylated by CHUK/IKKA at Ser-1382 and Ser-1386; these phosphorylations promote cell growth by switching the binding preference of CREBBP from TP53 to NF-kappa-B.</text>
</comment>
<comment type="PTM">
<text evidence="20">Sumoylation negatively regulates transcriptional activity via the recruitment of DAAX.</text>
</comment>
<comment type="PTM">
<text evidence="61">Autoacetylation is required for binding to protein substrates, such as acetylated histones and acetylated TP53/p53.</text>
</comment>
<comment type="disease">
<text>Chromosomal aberrations involving CREBBP may be a cause of acute myeloid leukemias. Translocation t(8;16)(p11;p13) with KAT6A; translocation t(11;16)(q23;p13.3) with KMT2A/MLL1; translocation t(10;16)(q22;p13) with KAT6B. KAT6A-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription.</text>
</comment>
<comment type="disease" evidence="34 45 46 56 59 61 63">
<disease id="DI-02730">
<name>Rubinstein-Taybi syndrome 1</name>
<acronym>RSTS1</acronym>
<description>A disorder characterized by craniofacial abnormalities, postnatal growth deficiency, broad thumbs, broad big toes, mental retardation and a propensity for development of malignancies.</description>
<dbReference type="MIM" id="180849"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="64">De novo missense mutations in the last part of exon 30 or beginning of exon 31 are associated with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features. No patients have broad thumbs. Patients have intellectual disability of variable severity, a marked speech delay, short stature and microcephaly. Main facial characteristics include short palpebral fissures, telecanthi, depressed nasal ridge, short nose, anteverted nares, short columella and long philtrum.</text>
</comment>
<comment type="sequence caution" evidence="71">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAE06125" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CBPID42.html"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/P300/CBP"/>
<text>P300/CBP entry</text>
</comment>
<dbReference type="EC" id="2.3.1.48" evidence="61"/>
<dbReference type="EMBL" id="U85962">
<property type="protein sequence ID" value="AAC51331.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U89354">
<property type="protein sequence ID" value="AAC51339.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U89355">
<property type="protein sequence ID" value="AAC51340.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U47741">
<property type="protein sequence ID" value="AAC51770.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB210043">
<property type="protein sequence ID" value="BAE06125.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471112">
<property type="protein sequence ID" value="EAW85335.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471112">
<property type="protein sequence ID" value="EAW85336.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471112">
<property type="protein sequence ID" value="EAW85337.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10509.1">
<molecule id="Q92793-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45399.1">
<molecule id="Q92793-2"/>
</dbReference>
<dbReference type="PIR" id="S39162">
<property type="entry name" value="S39162"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001073315.1">
<molecule id="Q92793-2"/>
<property type="nucleotide sequence ID" value="NM_001079846.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004371.2">
<molecule id="Q92793-1"/>
<property type="nucleotide sequence ID" value="NM_004380.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.459759"/>
<dbReference type="PDB" id="1JSP">
<property type="method" value="NMR"/>
<property type="chains" value="B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="1LIQ">
<property type="method" value="NMR"/>
<property type="chains" value="A=376-402"/>
</dbReference>
<dbReference type="PDB" id="1RDT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="E=58-80"/>
</dbReference>
<dbReference type="PDB" id="1WO3">
<property type="method" value="NMR"/>
<property type="chains" value="A=387-398"/>
</dbReference>
<dbReference type="PDB" id="1WO4">
<property type="method" value="NMR"/>
<property type="chains" value="A=387-398"/>
</dbReference>
<dbReference type="PDB" id="1WO5">
<property type="method" value="NMR"/>
<property type="chains" value="A=387-398"/>
</dbReference>
<dbReference type="PDB" id="1WO6">
<property type="method" value="NMR"/>
<property type="chains" value="A=376-400"/>
</dbReference>
<dbReference type="PDB" id="1WO7">
<property type="method" value="NMR"/>
<property type="chains" value="A=376-400"/>
</dbReference>
<dbReference type="PDB" id="1ZOQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="C/D=2065-2111"/>
</dbReference>
<dbReference type="PDB" id="2D82">
<property type="method" value="NMR"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="2KJE">
<property type="method" value="NMR"/>
<property type="chains" value="A=1763-1854"/>
</dbReference>
<dbReference type="PDB" id="2KWF">
<property type="method" value="NMR"/>
<property type="chains" value="A=587-673"/>
</dbReference>
<dbReference type="PDB" id="2L84">
<property type="method" value="NMR"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="2L85">
<property type="method" value="NMR"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="2LXS">
<property type="method" value="NMR"/>
<property type="chains" value="A=587-673"/>
</dbReference>
<dbReference type="PDB" id="2LXT">
<property type="method" value="NMR"/>
<property type="chains" value="A=587-673"/>
</dbReference>
<dbReference type="PDB" id="2N1A">
<property type="method" value="NMR"/>
<property type="chains" value="B=1699-1751"/>
</dbReference>
<dbReference type="PDB" id="2RNY">
<property type="method" value="NMR"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="3DWY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="3P1C">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="3P1D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="3P1E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="3P1F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="3SVH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4A9K">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4N3W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1080-1316"/>
</dbReference>
<dbReference type="PDB" id="4N4F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=1080-1316"/>
</dbReference>
<dbReference type="PDB" id="4NR4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4NR5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4NR6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4NR7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.20"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4NYV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A/B/C/D=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4NYW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.43"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4NYX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.10"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4OUF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A/B=1082-1197"/>
</dbReference>
<dbReference type="PDB" id="4TQN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4TS8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4WHU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="4YK0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B/C/D=1083-1196"/>
</dbReference>
<dbReference type="PDB" id="5CGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5DBM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="A/B/C=1082-1197"/>
</dbReference>
<dbReference type="PDB" id="5EIC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5ENG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.30"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5EP7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.20"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5GH9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A=1081-1196"/>
</dbReference>
<dbReference type="PDB" id="5H85">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5I83">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="A=1082-1197"/>
</dbReference>
<dbReference type="PDB" id="5I86">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.05"/>
<property type="chains" value="A/B=1082-1197"/>
</dbReference>
<dbReference type="PDB" id="5I89">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.07"/>
<property type="chains" value="A=1082-1197"/>
</dbReference>
<dbReference type="PDB" id="5I8B">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=1081-1312"/>
</dbReference>
<dbReference type="PDB" id="5I8G">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.41"/>
<property type="chains" value="A=1081-1312"/>
</dbReference>
<dbReference type="PDB" id="5J0D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.05"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5JEM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C/D/F/H=2065-2111"/>
</dbReference>
<dbReference type="PDB" id="5KTU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.38"/>
<property type="chains" value="A/B=1082-1197"/>
</dbReference>
<dbReference type="PDB" id="5KTW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.09"/>
<property type="chains" value="A/B/C=1085-1194"/>
</dbReference>
<dbReference type="PDB" id="5KTX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.27"/>
<property type="chains" value="A=1085-1194"/>
</dbReference>
<dbReference type="PDB" id="5LPJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5LPL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5MPZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5MQE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5MQG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5MQK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.53"/>
<property type="chains" value="A/B=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5NRW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5NU3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDB" id="5TB6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=1081-1197"/>
</dbReference>
<dbReference type="PDBsum" id="1JSP"/>
<dbReference type="PDBsum" id="1LIQ"/>
<dbReference type="PDBsum" id="1RDT"/>
<dbReference type="PDBsum" id="1WO3"/>
<dbReference type="PDBsum" id="1WO4"/>
<dbReference type="PDBsum" id="1WO5"/>
<dbReference type="PDBsum" id="1WO6"/>
<dbReference type="PDBsum" id="1WO7"/>
<dbReference type="PDBsum" id="1ZOQ"/>
<dbReference type="PDBsum" id="2D82"/>
<dbReference type="PDBsum" id="2KJE"/>
<dbReference type="PDBsum" id="2KWF"/>
<dbReference type="PDBsum" id="2L84"/>
<dbReference type="PDBsum" id="2L85"/>
<dbReference type="PDBsum" id="2LXS"/>
<dbReference type="PDBsum" id="2LXT"/>
<dbReference type="PDBsum" id="2N1A"/>
<dbReference type="PDBsum" id="2RNY"/>
<dbReference type="PDBsum" id="3DWY"/>
<dbReference type="PDBsum" id="3P1C"/>
<dbReference type="PDBsum" id="3P1D"/>
<dbReference type="PDBsum" id="3P1E"/>
<dbReference type="PDBsum" id="3P1F"/>
<dbReference type="PDBsum" id="3SVH"/>
<dbReference type="PDBsum" id="4A9K"/>
<dbReference type="PDBsum" id="4N3W"/>
<dbReference type="PDBsum" id="4N4F"/>
<dbReference type="PDBsum" id="4NR4"/>
<dbReference type="PDBsum" id="4NR5"/>
<dbReference type="PDBsum" id="4NR6"/>
<dbReference type="PDBsum" id="4NR7"/>
<dbReference type="PDBsum" id="4NYV"/>
<dbReference type="PDBsum" id="4NYW"/>
<dbReference type="PDBsum" id="4NYX"/>
<dbReference type="PDBsum" id="4OUF"/>
<dbReference type="PDBsum" id="4TQN"/>
<dbReference type="PDBsum" id="4TS8"/>
<dbReference type="PDBsum" id="4WHU"/>
<dbReference type="PDBsum" id="4YK0"/>
<dbReference type="PDBsum" id="5CGP"/>
<dbReference type="PDBsum" id="5DBM"/>
<dbReference type="PDBsum" id="5EIC"/>
<dbReference type="PDBsum" id="5ENG"/>
<dbReference type="PDBsum" id="5EP7"/>
<dbReference type="PDBsum" id="5GH9"/>
<dbReference type="PDBsum" id="5H85"/>
<dbReference type="PDBsum" id="5I83"/>
<dbReference type="PDBsum" id="5I86"/>
<dbReference type="PDBsum" id="5I89"/>
<dbReference type="PDBsum" id="5I8B"/>
<dbReference type="PDBsum" id="5I8G"/>
<dbReference type="PDBsum" id="5J0D"/>
<dbReference type="PDBsum" id="5JEM"/>
<dbReference type="PDBsum" id="5KTU"/>
<dbReference type="PDBsum" id="5KTW"/>
<dbReference type="PDBsum" id="5KTX"/>
<dbReference type="PDBsum" id="5LPJ"/>
<dbReference type="PDBsum" id="5LPL"/>
<dbReference type="PDBsum" id="5MPZ"/>
<dbReference type="PDBsum" id="5MQE"/>
<dbReference type="PDBsum" id="5MQG"/>
<dbReference type="PDBsum" id="5MQK"/>
<dbReference type="PDBsum" id="5NRW"/>
<dbReference type="PDBsum" id="5NU3"/>
<dbReference type="PDBsum" id="5TB6"/>
<dbReference type="ProteinModelPortal" id="Q92793"/>
<dbReference type="SMR" id="Q92793"/>
<dbReference type="BioGrid" id="107777">
<property type="interactions" value="323"/>
</dbReference>
<dbReference type="CORUM" id="Q92793"/>
<dbReference type="DIP" id="DIP-952N"/>
<dbReference type="ELM" id="Q92793"/>
<dbReference type="IntAct" id="Q92793">
<property type="interactions" value="84"/>
</dbReference>
<dbReference type="MINT" id="MINT-104685"/>
<dbReference type="STRING" id="9606.ENSP00000262367"/>
<dbReference type="BindingDB" id="Q92793"/>
<dbReference type="ChEMBL" id="CHEMBL5747"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2734"/>
<dbReference type="iPTMnet" id="Q92793"/>
<dbReference type="PhosphoSitePlus" id="Q92793"/>
<dbReference type="BioMuta" id="CREBBP"/>
<dbReference type="DMDM" id="116241283"/>
<dbReference type="EPD" id="Q92793"/>
<dbReference type="MaxQB" id="Q92793"/>
<dbReference type="PaxDb" id="Q92793"/>
<dbReference type="PeptideAtlas" id="Q92793"/>
<dbReference type="PRIDE" id="Q92793"/>
<dbReference type="Ensembl" id="ENST00000262367">
<molecule id="Q92793-1"/>
<property type="protein sequence ID" value="ENSP00000262367"/>
<property type="gene ID" value="ENSG00000005339"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000382070">
<molecule id="Q92793-2"/>
<property type="protein sequence ID" value="ENSP00000371502"/>
<property type="gene ID" value="ENSG00000005339"/>
</dbReference>
<dbReference type="GeneID" id="1387"/>
<dbReference type="KEGG" id="hsa:1387"/>
<dbReference type="UCSC" id="uc002cvv.4">
<molecule id="Q92793-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1387"/>
<dbReference type="DisGeNET" id="1387"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000005339.13"/>
<dbReference type="GeneCards" id="CREBBP"/>
<dbReference type="GeneReviews" id="CREBBP"/>
<dbReference type="HGNC" id="HGNC:2348">
<property type="gene designation" value="CREBBP"/>
</dbReference>
<dbReference type="HPA" id="CAB004212"/>
<dbReference type="HPA" id="HPA055861"/>
<dbReference type="MalaCards" id="CREBBP"/>
<dbReference type="MIM" id="180849">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600140">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92793"/>
<dbReference type="OpenTargets" id="ENSG00000005339"/>
<dbReference type="Orphanet" id="370026">
<property type="disease" value="Acute myeloid leukemia with t(8;16)(p11;p13) translocation"/>
</dbReference>
<dbReference type="Orphanet" id="353281">
<property type="disease" value="Rubinstein-Taybi syndrome due to 16p13.3 microdeletion"/>
</dbReference>
<dbReference type="Orphanet" id="353277">
<property type="disease" value="Rubinstein-Taybi syndrome due to CREBBP mutations"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26866"/>
<dbReference type="eggNOG" id="KOG1778">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5076">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119206"/>
<dbReference type="HOGENOM" id="HOG000111353"/>
<dbReference type="HOVERGEN" id="HBG000185"/>
<dbReference type="InParanoid" id="Q92793"/>
<dbReference type="KO" id="K04498"/>
<dbReference type="OMA" id="SGHSLMN"/>
<dbReference type="OrthoDB" id="EOG091G0L04"/>
<dbReference type="PhylomeDB" id="Q92793"/>
<dbReference type="TreeFam" id="TF101097"/>
<dbReference type="Reactome" id="R-HSA-1234158">
<property type="pathway name" value="Regulation of gene expression by Hypoxia-inducible Factor"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1368082">
<property type="pathway name" value="RORA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1368108">
<property type="pathway name" value="BMAL1:CLOCK,NPAS2 activates circadian gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1912408">
<property type="pathway name" value="Pre-NOTCH Transcription and Translation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-201722">
<property type="pathway name" value="Formation of the beta-catenin:TCF transactivating complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2032785">
<property type="pathway name" value="YAP1- and WWTR1 (TAZ)-stimulated gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2122947">
<property type="pathway name" value="NOTCH1 Intracellular Domain Regulates Transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2151201">
<property type="pathway name" value="Transcriptional activation of mitochondrial biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2426168">
<property type="pathway name" value="Activation of gene expression by SREBF (SREBP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2644606">
<property type="pathway name" value="Constitutive Signaling by NOTCH1 PEST Domain Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2894862">
<property type="pathway name" value="Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134973">
<property type="pathway name" value="LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214847">
<property type="pathway name" value="HATs acetylate histones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371568">
<property type="pathway name" value="Attenuation phase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-350054">
<property type="pathway name" value="Notch-HLH transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400206">
<property type="pathway name" value="Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6803204">
<property type="pathway name" value="TP53 Regulates Transcription of Genes Involved in Cytochrome C Release"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866907">
<property type="pathway name" value="Activation of the TFAP2 (AP-2) family of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939246">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of myeloid cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941856">
<property type="pathway name" value="RUNX3 regulates NOTCH signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951671">
<property type="pathway name" value="RUNX3 regulates YAP1-mediated transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983231">
<property type="pathway name" value="Factors involved in megakaryocyte development and platelet production"/>
</dbReference>
<dbReference type="SignaLink" id="Q92793"/>
<dbReference type="SIGNOR" id="Q92793"/>
<dbReference type="ChiTaRS" id="CREBBP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q92793"/>
<dbReference type="GeneWiki" id="CREB-binding_protein"/>
<dbReference type="GenomeRNAi" id="1387"/>
<dbReference type="PRO" id="PR:Q92793"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000005339"/>
<dbReference type="CleanEx" id="HS_CREBBP"/>
<dbReference type="ExpressionAtlas" id="Q92793">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92793">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000123">
<property type="term" value="C:histone acetyltransferase complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016407">
<property type="term" value="F:acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043426">
<property type="term" value="F:MRF binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034212">
<property type="term" value="F:peptide N-acetyltransferase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000987">
<property type="term" value="F:proximal promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001105">
<property type="term" value="F:RNA polymerase II transcription coactivator activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001078">
<property type="term" value="F:transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001191">
<property type="term" value="F:transcriptional repressor activity, RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1904837">
<property type="term" value="P:beta-catenin-TCF complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042733">
<property type="term" value="P:embryonic digit morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016573">
<property type="term" value="P:histone acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042592">
<property type="term" value="P:homeostatic process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018076">
<property type="term" value="P:N-terminal peptidyl-lysine acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006473">
<property type="term" value="P:protein acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006461">
<property type="term" value="P:protein complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1900034">
<property type="term" value="P:regulation of cellular response to heat"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019216">
<property type="term" value="P:regulation of lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045637">
<property type="term" value="P:regulation of myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008589">
<property type="term" value="P:regulation of smoothened signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061418">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to hypoxia"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048511">
<property type="term" value="P:rhythmic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd15802">
<property type="entry name" value="RING_CBP-p300"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.1630.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.1020.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.920.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001487">
<property type="entry name" value="Bromodomain"/>
</dbReference>
<dbReference type="InterPro" id="IPR036427">
<property type="entry name" value="Bromodomain-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018359">
<property type="entry name" value="Bromodomain_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR031162">
<property type="entry name" value="CBP_P300_HAT"/>
</dbReference>
<dbReference type="InterPro" id="IPR013178">
<property type="entry name" value="Histone_AcTrfase_Rtt109/CBP"/>
</dbReference>
<dbReference type="InterPro" id="IPR003101">
<property type="entry name" value="KIX_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036529">
<property type="entry name" value="KIX_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR009110">
<property type="entry name" value="Nuc_rcpt_coact"/>
</dbReference>
<dbReference type="InterPro" id="IPR014744">
<property type="entry name" value="Nuc_rcpt_coact_CREBbp"/>
</dbReference>
<dbReference type="InterPro" id="IPR037073">
<property type="entry name" value="Nuc_rcpt_coact_CREBbp_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR010303">
<property type="entry name" value="RING_CBP-p300"/>
</dbReference>
<dbReference type="InterPro" id="IPR035898">
<property type="entry name" value="TAZ_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000197">
<property type="entry name" value="Znf_TAZ"/>
</dbReference>
<dbReference type="InterPro" id="IPR000433">
<property type="entry name" value="Znf_ZZ"/>
</dbReference>
<dbReference type="Pfam" id="PF00439">
<property type="entry name" value="Bromodomain"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09030">
<property type="entry name" value="Creb_binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF06001">
<property type="entry name" value="DUF902"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08214">
<property type="entry name" value="HAT_KAT11"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02172">
<property type="entry name" value="KIX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02135">
<property type="entry name" value="zf-TAZ"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00569">
<property type="entry name" value="ZZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00503">
<property type="entry name" value="BROMODOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00297">
<property type="entry name" value="BROMO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01250">
<property type="entry name" value="KAT11"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00551">
<property type="entry name" value="ZnF_TAZ"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00291">
<property type="entry name" value="ZnF_ZZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47040">
<property type="entry name" value="SSF47040"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47370">
<property type="entry name" value="SSF47370"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57933">
<property type="entry name" value="SSF57933"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69125">
<property type="entry name" value="SSF69125"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00633">
<property type="entry name" value="BROMODOMAIN_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50014">
<property type="entry name" value="BROMODOMAIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51727">
<property type="entry name" value="CBP_P300_HAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50952">
<property type="entry name" value="KIX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50134">
<property type="entry name" value="ZF_TAZ"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS01357">
<property type="entry name" value="ZF_ZZ_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50135">
<property type="entry name" value="ZF_ZZ_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0103">Bromodomain</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="13 17">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="CREB-binding protein" id="PRO_0000211190">
<location>
<begin position="2"/>
<end position="2442"/>
</location>
</feature>
<feature type="domain" description="KIX" evidence="26">
<location>
<begin position="587"/>
<end position="666"/>
</location>
</feature>
<feature type="domain" description="Bromo" evidence="23">
<location>
<begin position="1103"/>
<end position="1175"/>
</location>
</feature>
<feature type="domain" description="CBP/p300-type HAT" evidence="27">
<location>
<begin position="1323"/>
<end position="1700"/>
</location>
</feature>
<feature type="zinc finger region" description="TAZ-type 1" evidence="24">
<location>
<begin position="347"/>
<end position="433"/>
</location>
</feature>
<feature type="zinc finger region" description="ZZ-type" evidence="25">
<location>
<begin position="1701"/>
<end position="1744"/>
</location>
</feature>
<feature type="zinc finger region" description="TAZ-type 2" evidence="24">
<location>
<begin position="1765"/>
<end position="1846"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SRCAP" evidence="29">
<location>
<begin position="227"/>
<end position="410"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with histone" evidence="60">
<location>
<begin position="1124"/>
<end position="1170"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ASF1A" evidence="61">
<location>
<begin position="1162"/>
<end position="1180"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with histone" evidence="22">
<location>
<begin position="1433"/>
<end position="1435"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="22">
<location>
<begin position="1434"/>
<end position="1436"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="22">
<location>
<begin position="1446"/>
<end position="1447"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TRERF1" evidence="35">
<location>
<begin position="1460"/>
<end position="1891"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1061"/>
<end position="1064"/>
</location>
</feature>
<feature type="compositionally biased region" description="Cys/His-rich">
<location>
<begin position="1199"/>
<end position="1487"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1555"/>
<end position="1562"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="1943"/>
<end position="1948"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="1967"/>
<end position="1970"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="2081"/>
<end position="2085"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="2199"/>
<end position="2216"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="2245"/>
<end position="2248"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="2297"/>
<end position="2300"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="20">
<location>
<position position="363"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="20">
<location>
<position position="367"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="20">
<location>
<position position="380"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="20">
<location>
<position position="385"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="20">
<location>
<position position="394"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="20">
<location>
<position position="398"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="20">
<location>
<position position="404"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="20">
<location>
<position position="409"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="20">
<location>
<position position="418"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="20">
<location>
<position position="422"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="20">
<location>
<position position="427"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="20">
<location>
<position position="430"/>
</location>
</feature>
<feature type="binding site" description="Acetyl-CoA; via carbonyl oxygen" evidence="22">
<location>
<position position="1493"/>
</location>
</feature>
<feature type="binding site" description="Acetyl-CoA" evidence="22">
<location>
<position position="1498"/>
</location>
</feature>
<feature type="binding site" description="Acetyl-CoA" evidence="22">
<location>
<position position="1502"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6B-CREBBP">
<location>
<begin position="29"/>
<end position="30"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6A-CREBBP">
<location>
<begin position="266"/>
<end position="267"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="13 17">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 16">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="19">
<location>
<position position="220"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylated arginine" evidence="20">
<location>
<position position="601"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylated arginine" evidence="20">
<location>
<position position="625"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="21">
<location>
<position position="657"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1014"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="1030"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="1076"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1216"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKA" evidence="57">
<location>
<position position="1382"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKA" evidence="57">
<location>
<position position="1386"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1583"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1591"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1592"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1595"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1597"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1741"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="1744"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="1763"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 15 18">
<location>
<position position="2063"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="2076"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="2079"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="2351"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="21">
<location>
<position position="998"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="21">
<location>
<position position="1033"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="21">
<location>
<position position="1056"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_045700" evidence="70">
<original>VAHCASSRQIISHWKNCTRHDCPVCLPLKNASDKRNQQT</original>
<variation>A</variation>
<location>
<begin position="406"/>
<end position="444"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs748447855." id="VAR_072912" evidence="63">
<original>Q</original>
<variation>H</variation>
<location>
<position position="503"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs902901184." id="VAR_072913" evidence="63">
<original>P</original>
<variation>T</variation>
<location>
<position position="532"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_072914" evidence="63">
<original>I</original>
<variation>N</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_072915" evidence="63">
<original>Y</original>
<variation>F</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1; dbSNP:rs746728741." id="VAR_072916" evidence="63">
<original>A</original>
<variation>T</variation>
<location>
<position position="789"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1; incomplete; dbSNP:rs143247685." id="VAR_072917" evidence="59">
<original>T</original>
<variation>A</variation>
<location>
<position position="910"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1; mild form; impairs binding to ASF1A and acetylated histone H3; dbSNP:rs28937315." id="VAR_037305" evidence="45 61 63">
<original>Y</original>
<variation>C</variation>
<location>
<position position="1175"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_072918" evidence="63">
<original>E</original>
<variation>A</variation>
<location>
<position position="1278"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1; abolishes acetyltransferase activity; dbSNP:rs267606752." id="VAR_035080" evidence="46 56">
<original>E</original>
<variation>K</variation>
<location>
<position position="1278"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1; abolishes acetyltransferase activity and the ability of transactivate CREB; dbSNP:rs121434626." id="VAR_015578" evidence="34 63">
<original>R</original>
<variation>P</variation>
<location>
<position position="1378"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_072919" evidence="63">
<original>D</original>
<variation>Y</variation>
<location>
<position position="1406"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs130015." id="VAR_027953">
<original>V</original>
<variation>I</variation>
<location>
<position position="1414"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_072920" evidence="63">
<original>Q</original>
<variation>P</variation>
<location>
<position position="1415"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_035081" evidence="56">
<original>T</original>
<variation>I</variation>
<location>
<position position="1447"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_035082" evidence="56">
<original>Y</original>
<variation>H</variation>
<location>
<position position="1450"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1; dbSNP:rs797044860." id="VAR_035083" evidence="56">
<original>H</original>
<variation>R</variation>
<location>
<position position="1470"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_072921" evidence="63">
<original>P</original>
<variation>T</variation>
<location>
<position position="1475"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_072922" evidence="63">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1503"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_072923" evidence="63">
<original>L</original>
<variation>P</variation>
<location>
<position position="1507"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1." id="VAR_072924" evidence="63">
<original>D</original>
<variation>N</variation>
<location>
<position position="1543"/>
</location>
</feature>
<feature type="sequence variant" description="In RSTS1; abolishes acetyltransferase activity." id="VAR_035084" evidence="46 56">
<original>R</original>
<variation>H</variation>
<location>
<position position="1664"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation." id="VAR_078557" evidence="64">
<original>C</original>
<variation>R</variation>
<location>
<position position="1710"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation." id="VAR_078558" evidence="64">
<original>L</original>
<variation>R</variation>
<location>
<position position="1747"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation." id="VAR_078559" evidence="64">
<original>R</original>
<variation>P</variation>
<location>
<position position="1786"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation." id="VAR_078560" evidence="64">
<original>C</original>
<variation>F</variation>
<location>
<position position="1819"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation." id="VAR_078561" evidence="64">
<original>C</original>
<variation>W</variation>
<location>
<position position="1826"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation." id="VAR_078562" evidence="64">
<original>C</original>
<variation>Y</variation>
<location>
<position position="1838"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation." id="VAR_078563" evidence="64">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1867"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation." id="VAR_078564" evidence="64">
<original>R</original>
<variation>W</variation>
<location>
<position position="1867"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation; dbSNP:rs886039491." id="VAR_078565" evidence="64">
<original>R</original>
<variation>W</variation>
<location>
<position position="1868"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in patient with growth retardation, craniofacial dysmorphism and additional Rubinstein-Taybi-like features; de novo mutation; dbSNP:rs797045037." id="VAR_078566" evidence="64">
<original>M</original>
<variation>V</variation>
<location>
<position position="1872"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to acetylated histones." evidence="61">
<original>D</original>
<variation>R</variation>
<location>
<position position="1116"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to acetylated histones." evidence="61">
<original>F</original>
<variation>A</variation>
<location>
<position position="1126"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with ASF1A." evidence="61">
<original>N</original>
<variation>E</variation>
<variation>R</variation>
<location>
<position position="1162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with ASF1A." evidence="61">
<original>W</original>
<variation>A</variation>
<location>
<position position="1165"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to acetylated histones." evidence="61">
<original>K</original>
<variation>E</variation>
<location>
<position position="1170"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with ASF1A." evidence="61">
<original>S</original>
<variation>I</variation>
<location>
<position position="1179"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with ASF1A." evidence="61">
<original>K</original>
<variation>E</variation>
<location>
<position position="1180"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with ASF1A." evidence="61">
<original>E</original>
<variation>R</variation>
<location>
<position position="1183"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC51340." ref="2" evidence="71">
<original>FAE</original>
<variation>NSG</variation>
<location>
<begin position="1511"/>
<end position="1513"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC51340." ref="2" evidence="71">
<original>ED</original>
<variation>VV</variation>
<location>
<begin position="1724"/>
<end position="1725"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC51770." ref="1" evidence="71">
<original>L</original>
<variation>V</variation>
<location>
<position position="1770"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC51340." ref="2" evidence="71">
<original>N</original>
<variation>F</variation>
<location>
<position position="1789"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC51340." ref="2" evidence="71">
<original>T</original>
<variation>P</variation>
<location>
<position position="1812"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="69"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="377"/>
<end position="379"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="383"/>
<end position="388"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="391"/>
<end position="395"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="593"/>
<end position="596"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="598"/>
<end position="612"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="618"/>
<end position="622"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="624"/>
<end position="642"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="647"/>
<end position="669"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="670"/>
<end position="672"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1087"/>
<end position="1102"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="1105"/>
<end position="1108"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1109"/>
<end position="1111"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1117"/>
<end position="1120"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1125"/>
<end position="1128"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1135"/>
<end position="1143"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="1146"/>
<end position="1149"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1150"/>
<end position="1167"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1169"/>
<end position="1171"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1173"/>
<end position="1195"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1214"/>
<end position="1218"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1226"/>
<end position="1230"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="1231"/>
<end position="1233"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1234"/>
<end position="1237"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="1238"/>
<end position="1240"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1266"/>
<end position="1272"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1280"/>
<end position="1282"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="1284"/>
<end position="1286"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1289"/>
<end position="1291"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1292"/>
<end position="1295"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="1309"/>
<end position="1311"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="1708"/>
<end position="1710"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="1718"/>
<end position="1721"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="1725"/>
<end position="1728"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="1730"/>
<end position="1736"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="1742"/>
<end position="1744"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1765"/>
<end position="1784"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1793"/>
<end position="1805"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="1811"/>
<end position="1815"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1817"/>
<end position="1832"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1841"/>
<end position="1853"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="2066"/>
<end position="2072"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="2080"/>
<end position="2091"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="2094"/>
<end position="2103"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="2104"/>
<end position="2106"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1JSP"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1LIQ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1RDT"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZOQ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KJE"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KWF"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L85"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2N1A"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I86"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I8G"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250"/>
<evidence key="21" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P45481"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q09472"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00035"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00203"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00228"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00311"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01065"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10077561"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10347196"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10722728"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10866662"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11154691"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11314014"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11331617"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11349124"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11463834"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11481323"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11514544"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11559821"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11568182"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11744733"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11864910"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11959977"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971985"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12114483"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12566391"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12730195"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12738767"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12929931"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14645221"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14716005"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14744133"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15075319"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15126506"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15220471"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15706485"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17434128"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18316612"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20684013"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24361270"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24616510"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24939902"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25388907"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27311832"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8684459"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8917528"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9323138"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9528808"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9707565"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="71" type="ECO:0000305"/>
<sequence length="2442" mass="265351" checksum="3BEA9B8558BA1A5E" modified="2006-10-17" version="3">
MAENLLDGPPNPKRAKLSSPGFSANDSTDFGSLFDLENDLPDELIPNGGELGLLNSGNLV
PDAASKHKQLSELLRGGSGSSINPGIGNVSASSPVQQGLGGQAQGQPNSANMASLSAMGK
SPLSQGDSSAPSLPKQAASTSGPTPAASQALNPQAQKQVGLATSSPATSQTGPGICMNAN
FNQTHPGLLNSNSGHSLINQASQGQAQVMNGSLGAAGRGRGAGMPYPTPAMQGASSSVLA
ETLTQVSPQMTGHAGLNTAQAGGMAKMGITGNTSPFGQPFSQAGGQPMGATGVNPQLASK
QSMVNSLPTFPTDIKNTSVTNVPNMSQMQTSVGIVPTQAIATGPTADPEKRKLIQQQLVL
LLHAHKCQRREQANGEVRACSLPHCRTMKNVLNHMTHCQAGKACQVAHCASSRQIISHWK
NCTRHDCPVCLPLKNASDKRNQQTILGSPASGIQNTIGSVGTGQQNATSLSNPNPIDPSS
MQRAYAALGLPYMNQPQTQLQPQVPGQQPAQPQTHQQMRTLNPLGNNPMNIPAGGITTDQ
QPPNLISESALPTSLGATNPLMNDGSNSGNIGTLSTIPTAAPPSSTGVRKGWHEHVTQDL
RSHLVHKLVQAIFPTPDPAALKDRRMENLVAYAKKVEGDMYESANSRDEYYHLLAEKIYK
IQKELEEKRRSRLHKQGILGNQPALPAPGAQPPVIPQAQPVRPPNGPLSLPVNRMQVSQG
MNSFNPMSLGNVQLPQAPMGPRAASPMNHSVQMNSMGSVPGMAISPSRMPQPPNMMGAHT
NNMMAQAPAQSQFLPQNQFPSSSGAMSVGMGQPPAQTGVSQGQVPGAALPNPLNMLGPQA
SQLPCPPVTQSPLHPTPPPASTAAGMPSLQHTTPPGMTPPQPAAPTQPSTPVSSSGQTPT
PTPGSVPSATQTQSTPTVQAAAQAQVTPQPQTPVQPPSVATPQSSQQQPTPVHAQPPGTP
LSQAAASIDNRVPTPSSVASAETNSQQPGPDVPVLEMKTETQAEDTEPDPGESKGEPRSE
MMEEDLQGASQVKEETDIAEQKSEPMEVDEKKPEVKVEVKEEEESSSNGTASQSTSPSQP
RKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKR
KLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLGYCC
GRKYEFSPQTLCCYGKQLCTIPRDAAYYSYQNRYHFCEKCFTEIQGENVTLGDDPSQPQT
TISKDQFEKKKNDTLDPEPFVDCKECGRKMHQICVLHYDIIWPSGFVCDNCLKKTGRPRK
ENKFSAKRLQTTRLGNHLEDRVNKFLRRQNHPEAGEVFVRVVASSDKTVEVKPGMKSRFV
DSGEMSESFPYRTKALFAFEEIDGVDVCFFGMHVQEYGSDCPPPNTRRVYISYLDSIHFF
RPRCLRTAVYHEILIGYLEYVKKLGYVTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQ
EWYKKMLDKAFAERIIHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEE
EERKKEESTAASETTEGSQGDSKNAKKKNNKKTNKNKSSISRANKKKPSMPNVSNDLSQK
LYATMEKHKEVFFVIHLHAGPVINTLPPIVDPDPLLSCDLMDGRDAFLTLARDKHWEFSS
LRRSKWSTLCMLVELHTQGQDRFVYTCNECKHHVETRWHCTVCEDYDLCINCYNTKSHAH
KMVKWGLGLDDEGSSQGEPQSKSPQESRRLSIQRCIQSLVHACQCRNANCSLPSCQKMKR
VVQHTKGCKRKTNGGCPVCKQLIALCCYHAKHCQENKCPVPFCLNIKHKLRQQQIQHRLQ
QAQLMRRRMATMNTRNVPQQSLPSPTSAPPGTPTQQPSTPQTPQPPAQPQPSPVSMSPAG
FPSVARTQPPTTVSTGKPTSQVPAPPPPAQPPPAAVEAARQIEREAQQQQHLYRVNINNS
MPPGRTGMGTPGSQMAPVSLNVPRPNQVSGPVMPSMPPGQWQQAPLPQQQPMPGLPRPVI
SMQAQAAVAGPRMPSVQPPRSISPSALQDLLRTLKSPSSPQQQQQVLNILKSNPQLMAAF
IKQRTAKYVANQPGMQPQPGLQSQPGMQPQPGMHQQPSLQNLNAMQAGVPRPGVPPQQQA
MGGLNPQGQALNIMNPGHNPNMASMNPQYREMLRRQLLQQQQQQQQQQQQQQQQQQGSAG
MAGGMAGHGQFQQPQGPGGYPPAMQQQQRMQQHLPLQGSSMGQMAAQMGQLGQMGQPGLG
ADSTPNIQQALQQRILQQQQMKQQIGSPGQPNPMSPQQHMLSGQPQASHLPGQQIATSLS
NQVRSPAPVQSPRPQSQPPHSSPSPRIQPQPSPHHVSPQTGSPHPGLAVTMASSIDQGHL
GNPEQSAMLPQLNTPSRSALSSELSLVGDTTGDTLEKFVEGL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>